跳至主要内容
临床试验/IRCT2016011626047N1
IRCT2016011626047N1已完成3 期

Comparison of efficacy and safety of topical Tranexamic Acid with and without using non-ablative fractional Erbium glass in patients with melasma refering to Razi Hospitallaser 1540nm for treatment of melasma in patients referred to Razi hospital

Vice chancellor for research,Tehran University of Medical Science0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • inclusion criteria: 18-65 years; symmetrical melasma in both half of the face; patients' satisfaction; skin type 1-5
  • exclusion criteria: use hidroquinone, topical and oral retinoid, topical steroid, alfa hydroxy acids and other drugs effect on pigmentation in past 4 weeks; use Oral Conterseptive Pill; chemical peeling,microderm abration, dermabratin or laser in past 3 months; history of past sensitivity to tranexamic acid; pregnancy; lactation; history ischemic or hemorrahgic events of coronal or cerebral artries

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Tehran University of Medical Science

相似试验